Announcement PDF Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Announcement Summary Entity name STARPHARMA HOLDINGS LIMITED Date of this announcement Friday December 08, 2023 The +securities the subject of this notification are: +Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX Total number of +securities to be issued/transferred ASX +security code Security description SPLAK PERFORMANCE RIGHT Refer to next page for full details of the announcement Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 1/7 Total number of +securities to be issued/transferred Issue date 667,441 08/12/2023 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Part 1 - Entity and announcement details 1.1 Name of entity STARPHARMA HOLDINGS LIMITED We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities. 1.2 Registered number type Registration number ACN 078532180 1.3 ASX issuer code SPL 1.4 The announcement is New announcement 1.5 Date of this announcement 8/12/2023 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 2/7 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Part 2 - Issue details 2.1 The +securities the subject of this notification are: +Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX 2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which: has an existing ASX security code ("existing class") Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 3/7 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B ASX +security code and description SPLAK : PERFORMANCE RIGHT Date the +securities the subject of this notification were issued 8/12/2023 Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class Yes Were any of the +securities issued to +key management personnel (KMP) or an +associate? Yes Provide details of the KMP or +associates being issued +securities. Name of KMP Name of registered holder Number of +securities JACINTH K FAIRLEY SAME 667,441 Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms https://www.starpharma.com/assets/uploads/2023-09/2023%20SPL%20Notice%20of%20AGM%20and%20Proxy%20For m%20Final.pdf Any other information the entity wishes to provide about the +securities the subject of this notification This notice is for the issuance of 667,441 CEO Rights to CEO Dr Fairley under the SPL Performance Rights Plan, approved by Shareholders at the 2023 AGM (refer to Resolution 6). This offer of performance rights is for the performance period starting from July 2023 to January 2024, whilst Dr Fairley is employed as CEO and Managing Director at Starpharma. The vesting of the CEO Rights is subject to the achievement of performance conditions as well as Corporate KPIs set during the performance period. Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 4/7 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Issue details Number of +securities 667,441 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 5/7 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Part 4 - +Securities on issue Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise: (A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.) 4.1 Quoted +Securities (Total number of each +class of +securities quoted) Total number of +securities on issue ASX +security code and description SPL : ORDINARY FULLY PAID 411,703,964 4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX) Total number of +securities on issue ASX +security code and description SPLAK : PERFORMANCE RIGHT Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 23,741,106 6/7 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Part 5 - Other Listing Rule requirements 5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1? Yes 5.1a Select the number of the applicable exception in Listing Rule 7.2 13 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 7/7